Shire Anticipates Vyvanse Approval “Any Day”
Firm also announces plan to acquire Vyvanse partner New River Pharmaceuticals for $2.6 billion in cash.
Firm also announces plan to acquire Vyvanse partner New River Pharmaceuticals for $2.6 billion in cash.